Advertisement

Advertisement

DE:82W Stock Latest News

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

The FlyModerately bullish activity in Hims and Hers Health with shares up 5.3%

Hims & Hers Health Ignites Rally on Weight-Loss Hype

PremiumWeekend Updates

Hims & Hers Health Ignites Rally on Weight-Loss Hype

9d ago

Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%

PremiumThe Fly

Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%

11d ago

Hims & Hers price target raised to $39 from $29 at Barclays

PremiumThe Fly

Hims & Hers price target raised to $39 from $29 at Barclays

12d ago

Hims & Hers Shareholders Reaffirm Board, Pay, and Auditor

PremiumCompany Announcements

Hims & Hers Shareholders Reaffirm Board, Pay, and Auditor

14d ago

Moderately bullish activity in Hims and Hers Health with shares up 10.7%

PremiumThe FlyModerately bullish activity in Hims and Hers Health with shares up 10.7%

14d ago

Moderately bullish activity in Hims and Hers Health with shares up 1.47%

The Fly

Moderately bullish activity in Hims and Hers Health with shares up 1.47%

20d ago

Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%

The Fly

Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 5.0%

25d ago

Hims & Hers appoints Anant Vinjamoori as CMO, Hims

PremiumThe Fly

Hims & Hers appoints Anant Vinjamoori as CMO, Hims

25d ago

Hims & Hers Reaffirmed at Buy as Analyst Sees Peptide Upside, Keeps $32 Price Target Unchanged

PremiumRatings

Hims & Hers Reaffirmed at Buy as Analyst Sees Peptide Upside, Keeps $32 Price Target Unchanged

26d ago

Hims & Hers Closes Eucalyptus Deal, Expands Global Platform

PremiumCompany Announcements

Hims & Hers Closes Eucalyptus Deal, Expands Global Platform

27d ago

Hims & Hers announces expansion of Hims & Hers Benefits

PremiumThe Fly

Hims & Hers announces expansion of Hims & Hers Benefits

1M ago

Moderately bullish activity in Hims and Hers Health with shares down 0.32%

PremiumThe FlyModerately bullish activity in Hims and Hers Health with shares down 0.32%

1M ago

Hims & Hers price target lowered to $25 from $28 at BofA

The Fly

Hims & Hers price target lowered to $25 from $28 at BofA

1M ago

Hims & Hers price target raised to $23 from $18 at Truist

The Fly

Hims & Hers price target raised to $23 from $18 at Truist

1M ago

Hims & Hers issues convertible notes and capped calls

PremiumCompany Announcements

Hims & Hers issues convertible notes and capped calls

1M ago

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

PremiumThe Fly

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

1M ago

Hims & Hers expands GLP-1 offering in Canada with generic Semaglutide

PremiumThe Fly

Hims & Hers expands GLP-1 offering in Canada with generic Semaglutide

1M ago

Hims & Hers Plans $300M Convertible Notes for Expansion

PremiumCompany Announcements

Hims & Hers Plans $300M Convertible Notes for Expansion

1M ago

Hims & Hers price target lowered to $28 from $30 at BofA

PremiumThe FlyHims & Hers price target lowered to $28 from $30 at BofA

1M ago

Hims & Hers announces proposed convertible senior notes offering

The Fly

Hims & Hers announces proposed convertible senior notes offering

1M ago

Hims & Hers price target lowered to $30 from $32 at BofA

The Fly

Hims & Hers price target lowered to $30 from $32 at BofA

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >